Skip to content

Drug interactions

Argatroban + Pegaspargase

Severity: Moderate

Argatroban and Pegaspargase: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pegaspargase lowers synthesis of coagulation factors and can cause both bleeding and thrombosis. With argatroban, bleeding risk is increased, and baseline coagulopathy can also make aPTT monitoring harder to interpret.

What this interaction means in plain words

Argatroban and Pegaspargase can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Argatroban belongs to Cardiovascular; Pegaspargase belongs to Oncology.

Evidence level: Moderate

Why it happens

Asparaginase-induced depletion of clotting factors adds to anticoagulant effect.

What to do

Monitor coagulation parameters including fibrinogen and aPTT, and watch for bleeding. Adjust argatroban dosing based on clinical and laboratory response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Argatroban and Pegaspargase, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Argatroban with Pegaspargase?

MediHelp rates the interaction as moderate. Argatroban and Pegaspargase can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pegaspargase lowers synthesis of coagulation factors and can cause both bleeding and thrombosis. With argatroban, bleeding risk is increased, and baseline coagulopathy can also make aPTT monitoring harder to interpret.

How serious is the interaction between Argatroban and Pegaspargase?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor coagulation parameters including fibrinogen and aPTT, and watch for bleeding. Adjust argatroban dosing based on clinical and laboratory response.

What other medicines interact with Argatroban?

MediHelp also lists interactions of Argatroban with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Argatroban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in